Deutsche Bank views the 2027 Medicare Advantage and Part D rate announcement last night from the Centers for Medicare and Medicaid Services as a “positive surprise” for the managed care stocks in the near term. The expected average change in revenue represented almost 240 basis points of increase compared to the proposed 0.09% in the advance rate notice, the analyst tells investors in a research note. However, Deutsche says 2.48% does not represent a rate that appears in-line with cost trends and could lead to continued margin pressure on the Medicare Advantage space in 2027. The firm points out Humana (HUM), UnitedHealth (UNH), CVS Health (CVS), Elevance Health (ELV), Centene (CNC) and Molina Healthcare (MOH) were up mid to high single digit percentages following the announcement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Morning Movers: Broadcom gains following pact to supply custom TPUs for Google
- Humana price target raised to $210 from $196 at BofA
- Humana price target raised to $227 from $206 at Wells Fargo
- UnitedHealth (UNH) or Humana (HUM): Which Stock Is the Better Buy After CMS’ Surprise Rate Hike
- Closing Bell Movers: Health insurers rise on higher Medicare rate hike
